News about Soliton Incorporated

Soliton Appoints Mary Stoll as Senior Director of Clinical Development
Posted 12/10/2019
Soliton Initiates Significant Step Towards Commercialization
Posted 12/3/2019

Soliton and Emphysys Enter Into a 3-year Development Agreement
Posted 11/21/2019
Soliton Announces First Follow-up Visit Conducted in the Pivotal Cellulite Clinical Trial
Posted 11/12/2019

Soliton Completes Treatment of All Patients in Pivotal Cellulite Trial
Posted 11/5/2019
Soliton's Recent Positive Data Increases Potential Fibrotic Indications
Posted 10/29/2019

Soliton's FDA Cleared RAP Device is Granted Two Additional Key Patents
Posted 10/15/2019